Rocket


Overview
Financials
News + Filings

 
 

Allarity Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues0.00.1
            Revenue growth-100.0% 
Cost of goods sold0.00.0
Gross profit0.00.1
            Gross margin 100.0%
Research and development5.16.4
General and administrative4.13.9
EBIT-8.4-10.1
            EBIT margin -8430.8%
Pre-tax income-5.1-14.4
Income taxes2.24.6
Net income-7.2-18.9
            Net margin -15741.7%
 
Diluted EPS($0.04)($0.30)
Shares outstanding (diluted)172.763.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy